About
Applicator-free, dissolving, microneedle patch technology
Areas of Focus
Categories
Drug Delivery & FormulationSoutheastern U.S.
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
364
By Phase
PHASE1: 1PHASE1/PHASE2: 1NA: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06962904Collaborator
CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults
PHASE1Recruiting
50 participants
Started: Jul 7, 2025 · Completed: Jul 15, 2027
NCT04394689Lead Sponsor
Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial
PHASE1/PHASE2Completed
281 participants
Started: May 19, 2021 · Completed: Dec 31, 2022
NCT03207763Collaborator
Microneedle Patch Study in Healthy Infants/Young Children
NACompleted
33 participants
Started: Jul 11, 2017 · Completed: May 15, 2019
Locations (1)
Headquarters
Atlanta, GA, United States
Map
Loading map...